Whittier Trust Co. boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 32.1% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 96,038 shares of the healthcare conglomerate’s stock after acquiring an additional 23,349 shares during the period. Whittier Trust Co.’s holdings in UnitedHealth Group were worth $36,427,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. TIAA Trust National Association grew its stake in shares of UnitedHealth Group by 47.3% during the 3rd quarter. TIAA Trust National Association now owns 2,384 shares of the healthcare conglomerate’s stock worth $875,000 after acquiring an additional 765 shares during the period. Saranac Partners Ltd raised its stake in UnitedHealth Group by 7.8% in the 3rd quarter. Saranac Partners Ltd now owns 21,594 shares of the healthcare conglomerate’s stock valued at $8,787,000 after acquiring an additional 1,562 shares during the period. Patron Partners LLC lifted its holdings in UnitedHealth Group by 19.2% during the third quarter. Patron Partners LLC now owns 2,893 shares of the healthcare conglomerate’s stock valued at $1,062,000 after purchasing an additional 465 shares during the last quarter. Advisors Asset Management Inc. bought a new position in UnitedHealth Group during the third quarter worth about $38,639,000. Finally, Private Wealth Asset Management LLC increased its stake in shares of UnitedHealth Group by 127.1% in the third quarter. Private Wealth Asset Management LLC now owns 9,794 shares of the healthcare conglomerate’s stock worth $3,860,000 after purchasing an additional 5,481 shares in the last quarter. 87.86% of the stock is owned by institutional investors.
UnitedHealth Group Trading Up 2.9%
Shares of UNH opened at $339.92 on Friday. UnitedHealth Group Incorporated has a twelve month low of $255.96 and a twelve month high of $461.62. The stock has a market cap of $304.57 billion, a PE ratio of 19.41, a P/E/G ratio of 1.49 and a beta of 0.51. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. The business’s 50-day moving average price is $388.64 and its 200-day moving average price is $367.55.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, beating analysts’ consensus estimates of $4.14 by $0.55. The company had revenue of $112.72 billion during the quarter, compared to analyst estimates of $111.31 billion. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. UnitedHealth Group’s revenue was down .4% compared to the same quarter last year. During the same period last year, the business earned $2.59 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 20.61 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Monday, December 7th will be issued a $2.32 dividend. This represents a $9.28 annualized dividend and a yield of 2.7%. The ex-dividend date of this dividend is Monday, December 7th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 53.00%.
Analysts Set New Price Targets
Several research firms have recently issued reports on UNH. New Street Research set a $402.00 price target on shares of UnitedHealth Group in a research report on Friday, October 9th. Wall Street Zen upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Piper Sandler boosted their target price on shares of UnitedHealth Group from $502.00 to $504.00 and gave the company an “overweight” rating in a report on Wednesday, October 14th. UBS Group restated an “outperform” rating on shares of UnitedHealth Group in a research report on Tuesday, October 13th. Finally, Stephens set a $500.00 price target on UnitedHealth Group in a report on Friday, October 16th. Twenty-one investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $465.70.
View Our Latest Research Report on UNH
Key UnitedHealth Group News
Here’s some of the latest news about UNH:
- Positive Sentiment: TD Cowen raised its rating on UnitedHealth to Buy from Hold, increased its price target to $455 from $402, and named it a 2027 best idea. The firm sees a clearer path to stronger earnings as Medicare Advantage pricing becomes more rational, with mid-to-high-teens EPS growth possible. Article: UnitedHealth stock pops on Buy rating, price target raise from TD Cowen
- Neutral Sentiment: UnitedHealth is suing the U.S. government over lowered Medicare Advantage star ratings. The challenge could contest a decision affecting the business, but the outcome and financial implications are unclear. Article: UnitedHealth sues US government over lowered Medicare Advantage star ratings
- Negative Sentiment: Investors remain concerned about proposed CMS Medicare Advantage audit and repayment rules, which could extend audit findings across contracts and reach back to earlier payment years. Those concerns have weighed on managed-care stocks and contributed to UnitedHealth’s recent decline. Article: UnitedHealth Shares Sink as New Federal Fraud Crackdown Sparks Healthcare Sell-Off
About UnitedHealth Group
UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.
Further Reading
- Five stocks we like better than UnitedHealth Group
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
- MarketBeat Week in Review – 11/16 – 11/20
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
